NIH Launches Center for Vaccine and Infection Research
The center in Bethesda will study patients experiencing health problems following vaccination or infection.
Updated on Oct. 20, 2026 in COVID-19
Live Poll
Do you trust the federal government to appropriately investigate and treat reported vaccine injuries?
The National Institutes of Health has opened a new research center on its Bethesda, Maryland, campus to study individuals dealing with health issues after vaccination or infection. Health Secretary Robert F. Kennedy Jr. announced the opening on October 8, 2026.
Why it matters
The new facility aims to investigate the biological mechanisms connecting vaccination or infection to persistent health problems. Researchers intend to use these findings to develop effective treatments for affected patients.
The NIH is currently coordinating clinical trial enrollment for several hundred patients to study health outcomes. Interested individuals may sign up by calling 800-411-1222 or emailing clinicalstudiescc.nih.gov.
The players
National Institutes of Health
The agency is the primary biomedical research organization of the United States government.
Robert F. Kennedy Jr.
He currently serves as the Health Secretary of the United States.
The details
The NIH is currently developing a comprehensive study protocol to analyze patients experiencing serious post-vaccination or post-infection adverse effects. The center plans to initiate this study before the end of 2026 as it works to identify potential clinical interventions.
Timeline
October 8, 2026: Secretary Robert F. Kennedy Jr. announced the opening of the new research center.
Before the end of 2026: The NIH expects to launch its patient study protocol.
The Big Picture
This research initiative builds upon the National Institutes of Health's clinical trial enrollment protocols. By establishing a dedicated facility, the agency is expanding its established research infrastructure to address previously under-researched health conditions.
Patients experiencing persistent health problems following vaccination or infection may now seek enrollment in the upcoming NIH study. Interested parties can facilitate the screening process by utilizing the center's provided contact channels.
The takeaway
This facility represents a formal effort by federal health authorities to address the clinical needs of patients with lingering health concerns. Individuals interested in participating should maintain regular contact with the center as the 2026 study launch approaches.
What happens next
The NIH is expected to finalize its study protocol and begin recruiting participants before the end of 2026.
Further reading
For broader context on current initiatives, explore more on COVID-19.
Source note: This article includes information reported by Theepochtimes.
Live Poll
Do you trust the federal government to appropriately investigate and treat reported vaccine injuries?
